...
search icon
inm-img

InMed Pharmaceuticals Inc Share Price

INM
NAQ
$0.876
+$0.03
(3.53%)
1D
Industry: Biotechnology Sector: Health Care

InMed Pharmaceuticals Inc Analyst Forecast

InMed Pharmaceuticals Inc Share Price Chart

InMed Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.48M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
49.73K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.40
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.85 L
$5.5 H
$0.876

About InMed Pharmaceuticals Inc, Common Stock

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol topical skin cream that has completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, a small molecule compound that acts as a selective dual CB1/CB2 agonist; and INM-900 for neurodegenerative diseases, as well as INM-901, a small molecule for treatment of Alzheimer's disease. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. more

Industry: BiotechnologySector: Health Care

InMed Pharmaceuticals Inc Stock Returns

Time FrameINMSectorS&P500
1-Week Return-13.23%0.72%-1.31%
1-Month Return-19.72%1.27%0.78%
3-Month Return-41.16%3.13%3.46%
6-Month Return-62.65%15.81%6.19%
1-Year Return-72.9%8.89%11.68%
3-Year Return-97.1%20.79%71.21%
5-Year Return-99.96%35.89%74.81%
10-Year Return-99.96%138.44%256.59%

InMed Pharmaceuticals Inc Financials

Jun '21Jun '22Jun '23Jun '24Jun '255YR TREND
Total Revenue-1.09M4.14M4.60M4.94M[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":22.04,"profit":true},{"date":"2023-06-30","value":83.67,"profit":true},{"date":"2024-06-30","value":93.02,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Cost of Revenue197.03K545.89K2.73M3.50M3.24M[{"date":"2021-06-30","value":5.63,"profit":true},{"date":"2022-06-30","value":15.61,"profit":true},{"date":"2023-06-30","value":78.14,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-06-30","value":92.54,"profit":true}]
Gross Profit(197.03K)543.55K1.40M1.10M1.71M[{"date":"2021-06-30","value":-11.55,"profit":false},{"date":"2022-06-30","value":31.85,"profit":true},{"date":"2023-06-30","value":82.21,"profit":true},{"date":"2024-06-30","value":64.51,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Gross Margin-49.89%33.93%23.94%34.53%[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":68,"profit":true},{"date":"2024-06-30","value":47.99,"profit":true},{"date":"2025-06-30","value":69.2,"profit":true}]
Operating Expenses12.17M14.34M9.78M9.24M9.62M[{"date":"2021-06-30","value":84.9,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":68.24,"profit":true},{"date":"2024-06-30","value":64.42,"profit":true},{"date":"2025-06-30","value":67.14,"profit":true}]
Operating Income(12.17M)(13.79M)(8.38M)(8.13M)(7.92M)[{"date":"2021-06-30","value":-1217114200,"profit":false},{"date":"2022-06-30","value":-1379175600,"profit":false},{"date":"2023-06-30","value":-837878700,"profit":false},{"date":"2024-06-30","value":-813443000,"profit":false},{"date":"2025-06-30","value":-791799500,"profit":false}]
Total Non-Operating Income/Expense(822.47K)(4.71M)936.71K993.88K(459.81K)[{"date":"2021-06-30","value":-82.75,"profit":false},{"date":"2022-06-30","value":-474.13,"profit":false},{"date":"2023-06-30","value":94.25,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2025-06-30","value":-46.26,"profit":false}]
Pre-Tax Income(12.65M)(18.60M)(7.93M)(7.67M)(8.16M)[{"date":"2021-06-30","value":-1264927900,"profit":false},{"date":"2022-06-30","value":-1860011700,"profit":false},{"date":"2023-06-30","value":-793452200,"profit":false},{"date":"2024-06-30","value":-766845000,"profit":false},{"date":"2025-06-30","value":-816213300,"profit":false}]
Income Taxes360.35K4.81M13.10K7.10K-[{"date":"2021-06-30","value":7.49,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":0.27,"profit":true},{"date":"2024-06-30","value":0.15,"profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Income After Taxes(13.01M)(23.41M)(7.95M)(7.68M)-[{"date":"2021-06-30","value":-1300962900,"profit":false},{"date":"2022-06-30","value":-2340847800,"profit":false},{"date":"2023-06-30","value":-794762200,"profit":false},{"date":"2024-06-30","value":-767555000,"profit":false},{"date":"2025-06-30","value":"-","profit":true}]
Income From Continuous Operations(10.20M)(18.60M)(7.95M)(7.68M)(8.16M)[{"date":"2021-06-30","value":-1020308900,"profit":false},{"date":"2022-06-30","value":-1860011700,"profit":false},{"date":"2023-06-30","value":-794762200,"profit":false},{"date":"2024-06-30","value":-767555000,"profit":false},{"date":"2025-06-30","value":-816213300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Net Income(12.65M)(18.60M)(7.95M)(7.68M)(8.16M)[{"date":"2021-06-30","value":-1264927900,"profit":false},{"date":"2022-06-30","value":-1860011700,"profit":false},{"date":"2023-06-30","value":-794762200,"profit":false},{"date":"2024-06-30","value":-767555000,"profit":false},{"date":"2025-06-30","value":-816213300,"profit":false}]
EPS (Diluted)(30.09)(34.28)(8.82)(14.53)(7.00)[{"date":"2021-06-30","value":-3009,"profit":false},{"date":"2022-06-30","value":-3428,"profit":false},{"date":"2023-06-30","value":-882,"profit":false},{"date":"2024-06-30","value":-1452.82,"profit":false},{"date":"2025-06-30","value":-699.7,"profit":false}]

InMed Pharmaceuticals Inc Ratios

InMed Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

INM
Cash Ratio 4.73
Current Ratio 5.94
Quick Ratio 5.30

InMed Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INM
ROA (LTM) -49.77%
ROE (LTM) -97.20%

InMed Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INM
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

InMed Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INM
Trailing PE NM
Forward PE NM
P/S (TTM) 0.57
P/B 0.21
Price/FCF NM
EV/R 0.12
EV/Ebitda 1.00

FAQs

What is InMed Pharmaceuticals Inc share price today?

InMed Pharmaceuticals Inc (INM) share price today is $0.876

Can Indians buy InMed Pharmaceuticals Inc shares?

Yes, Indians can buy shares of InMed Pharmaceuticals Inc (INM) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of InMed Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of InMed Pharmaceuticals Inc (INM) via the Vested app. You can start investing in InMed Pharmaceuticals Inc (INM) with a minimum investment of $1.

How to invest in InMed Pharmaceuticals Inc shares from India?

You can invest in shares of InMed Pharmaceuticals Inc (INM) via Vested in three simple steps:

  • Click on Sign Up or Invest in INM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in InMed Pharmaceuticals Inc shares
What is InMed Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of InMed Pharmaceuticals Inc (INM) is $5.5. The 52-week low price of InMed Pharmaceuticals Inc (INM) is $0.85.

What is InMed Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of InMed Pharmaceuticals Inc (INM) is

What is InMed Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of InMed Pharmaceuticals Inc (INM) is 0.21

What is InMed Pharmaceuticals Inc dividend yield?

The dividend yield of InMed Pharmaceuticals Inc (INM) is 0.00%

What is the Market Cap of InMed Pharmaceuticals Inc?

The market capitalization of InMed Pharmaceuticals Inc (INM) is $2.48M

What is InMed Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of InMed Pharmaceuticals Inc is INM

How Can Investors Use InMed Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of InMed Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether InMed Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from InMed Pharmaceuticals Inc shares for Indian investors?

When investing in InMed Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the InMed Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare InMed Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of InMed Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that InMed Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top